Literature DB >> 15948780

The cut-and-paste method for primary pterygium surgery: long-term follow-up.

Gabor Koranyi1, Stefan Seregard, Eva Dafgård Kopp.   

Abstract

OBJECTIVE: To evaluate the recurrence rate, reoperation rate and side-effects of a novel technique for pterygium surgery.
DESIGN: Retrospective study. PARTICIPANTS: The study included 461 eyes of 381 patients operated for primary nasal pterygium by the same surgeon between 1994 and 2003 and followed for 23 +/- 20 months (range 6-112 months).
METHODS: Autologous conjunctival grafts harvested at the superotemporal limbus were used to cover the sclera after pterygium excision. Using a retrospective chart review, the outcome after attaching the transplant to the sclera with a fibrin tissue adhesive (n = 325) was compared to the outcome after graft attachment using absorbable sutures (n = 136). MAIN OUTCOME MEASURES: Recurrence rate, reoperation rate and complications.
RESULTS: The recurrence rate was 5.3% in the glue group and 13.5% in the suture group (p = 0.01). The reoperation rates were 1.2% and 3.3%, respectively (p = 0.31). Complications, such as transient transplant oedema and persistent corneal epithelial defects, occurred equally in both groups.
CONCLUSION: Using a fibrin tissue adhesive instead of sutures when attaching the conjunctival transplant in primary pterygium surgery results in a significantly lower recurrence rate.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15948780     DOI: 10.1111/j.1600-0420.2005.00465.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  27 in total

1.  Sutureless amniotic membrane transplantation combined with narrow-strip conjunctival autograft for pterygium.

Authors:  Hande Taylan Sekeroglu; Elif Erdem; Nese Cetin Dogan; Meltem Yagmur; Reha Ersoz; Ahmet Dogan
Journal:  Int Ophthalmol       Date:  2011-12-07       Impact factor: 2.031

2.  Epithelial ingrowth following surgery of recurrent pterygium.

Authors:  Sambuddha Ghosh; Subhalakshmi Mukhopadhyay
Journal:  Int Ophthalmol       Date:  2007-06-22       Impact factor: 2.031

3.  Sutureless amniotic membrane transplantation for partial limbal stem cell deficiency.

Authors:  Ahmad Kheirkhah; Victoria Casas; Vadrevu K Raju; Scheffer C G Tseng
Journal:  Am J Ophthalmol       Date:  2008-03-10       Impact factor: 5.258

4.  A comparison between fibrin sealant and sutures for attaching conjunctival autograft after pterygium excision.

Authors:  Nitin Vichare; Tarun Choudhary; Priyanka Arora
Journal:  Med J Armed Forces India       Date:  2012-12-29

5.  Fibrin glue inhibits migration of ocular surface epithelial cells.

Authors:  A M Yeung; L A Faraj; O D McIntosh; V K Dhillon; H S Dua
Journal:  Eye (Lond)       Date:  2016-07-01       Impact factor: 3.775

Review 6.  Developments and current approaches in the treatment of pterygium.

Authors:  Dilek Hacıoğlu; Hidayet Erdöl
Journal:  Int Ophthalmol       Date:  2016-09-23       Impact factor: 2.031

7.  Comparison of autologous fibrin glue versus nylon sutures for securing conjunctival autografting in pterygium surgery.

Authors:  Daryoush Hamidi Alamdari; Mohamad-Reza Sedaghat; Reza Alizadeh; Siamak Zarei-Ghanavati; Hashem Naseri; Fatemeh Sharifi
Journal:  Int Ophthalmol       Date:  2017-06-17       Impact factor: 2.031

8.  Self-made cryopreservative fibrin glue applied in pterygium surgery: a novel practical technique.

Authors:  Jing-Wen Gong; Jun-Hao Chen; Ting Shen; Jin Jiang
Journal:  Int Ophthalmol       Date:  2017-07-03       Impact factor: 2.031

9.  Sutureless, Glue-less Conjunctival Autograft versus Conjunctival Autograft with Sutures for Primary, Advanced Pterygia: An Interventional Pilot study.

Authors:  Tanie Natung; Avonuo Keditsu; Wakaru Shullai; Prasanta Kumar Goswami
Journal:  J Clin Diagn Res       Date:  2017-08-01

Review 10.  Fibrin glue in ophthalmology.

Authors:  Anita Panda; Sandeep Kumar; Abhiyan Kumar; Raseena Bansal; Shibal Bhartiya
Journal:  Indian J Ophthalmol       Date:  2009 Sep-Oct       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.